Bristol Myers Squibb
LeaveRussia detail: Withdrawal
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Business in Russia
The Russian Ministry of Health has revoked the state registration of two anti-tumor drugs used to treat various types of blood cancer: Revlimid and Imnovid. The rights to both drugs belong to the American pharmaceutical company Bristol-Myers Squibb (BMS), which left the Russian market after the war began.
Decision trail
Decision date 02/06/2022 · Reference ↗
BMS is handing over its Russian commercial operations to its distribution partner Swixx Healthcare, previously known as Amicus, a Bristol spokesperson said over email
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — exited · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional